These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 19407174)

  • 1. Newsmaker interview. Defying skeptics, Richard Scheller thinks Genentech will thrive. Interview by Greg Miller.
    Scheller R
    Science; 2009 May; 324(5927):583. PubMed ID: 19407174
    [No Abstract]   [Full Text] [Related]  

  • 2. Newsmaker interview. Genentech scientist to take the helm at Rockefeller University. Interview by Greg Miller.
    Tessier-Lavigne M
    Science; 2010 Sep; 329(5998):1456. PubMed ID: 20847242
    [No Abstract]   [Full Text] [Related]  

  • 3. Joseph Miletich talks about big Pharma, biotech and the future of Amgen. Interview by Steve Carney.
    Miletich JP
    Drug Discov Today; 2006 Mar; 11(5-6):188-90. PubMed ID: 16580595
    [No Abstract]   [Full Text] [Related]  

  • 4. Indian biotechnology--rapidly evolving and industry led.
    Kumar NK; Quach U; Thorsteinsdóttir H; Somsekhar H; Daar AS; Singer PA
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC31-6. PubMed ID: 15583682
    [No Abstract]   [Full Text] [Related]  

  • 5. Fates intertwined.
    Cooper GJ
    Nat Biotechnol; 2006 Mar; 24(3):252-4. PubMed ID: 16525372
    [No Abstract]   [Full Text] [Related]  

  • 6. South Korean biotechnology--a rising industrial and scientific powerhouse.
    Wong J; Quach U; Thorsteinsdóttir H; Singer PA; Daar AS
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC42-7. PubMed ID: 15583684
    [No Abstract]   [Full Text] [Related]  

  • 7. The emergence of Egyptian biotechnology from generics.
    Abdelgafar B; Thorsteinsdóttir H; Quach U; Singer PA; Daar AS
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC25-30. PubMed ID: 15583680
    [No Abstract]   [Full Text] [Related]  

  • 8. Newsmaker interview. Corey Goodman, post-Pfizer, on the allure of enterprise. Interview by Jennifer Couzin-Frankel.
    Goodman C
    Science; 2009 May; 324(5928):706. PubMed ID: 19423785
    [No Abstract]   [Full Text] [Related]  

  • 9. Genentech makes its first-ever acquisition.
    Hollmer M
    Nat Biotechnol; 2007 Jan; 25(1):4-5. PubMed ID: 17211375
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotech boot camp.
    Ledford H
    Nature; 2015 Mar; 519(7544):402-5. PubMed ID: 25810186
    [No Abstract]   [Full Text] [Related]  

  • 11. Newsmaker interview: Laurence Steinberg. Supreme Court cites science in limiting punishments for juveniles. Interview by Greg Miller.
    Steinberg L
    Science; 2012 Jul; 337(6090):25. PubMed ID: 22767907
    [No Abstract]   [Full Text] [Related]  

  • 12. Study critiques corporate control of trials.
    Niiler E
    Nat Biotechnol; 2002 Dec; 20(12):1180. PubMed ID: 12454659
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug development and the FDA's Critical Path Initiative.
    Woosley RL; Cossman J
    Clin Pharmacol Ther; 2007 Jan; 81(1):129-33. PubMed ID: 17186012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Around the world in a month.
    Nat Biotechnol; 2015 Sep; 33(9):896. PubMed ID: 26348948
    [No Abstract]   [Full Text] [Related]  

  • 15. The difficulties industry is facing with investigators.
    Blackledge GR
    Eur J Cancer; 2005 Oct; 41(15):2210-2. PubMed ID: 16214043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update of FDA's Critical Path Initiative.
    Khleif S
    Clin Adv Hematol Oncol; 2009 Mar; 7(3):173-4. PubMed ID: 19398939
    [No Abstract]   [Full Text] [Related]  

  • 17. Trials and error.
    Jacobs T
    Nat Biotechnol; 2005 Dec; 23(12):1481. PubMed ID: 16333284
    [No Abstract]   [Full Text] [Related]  

  • 18. Novartis to shut brain research facility.
    Abbott A
    Nature; 2011 Dec; 480(7376):161-2. PubMed ID: 22158218
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical device research.
    Boyle J; Maeder A; Bell J; John S; Scott R
    Expert Rev Med Devices; 2005 Jan; 2(1):41-5. PubMed ID: 16293027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roche vows to keep Genentech culture.
    Hayden EC
    Nature; 2009 Mar; 458(7236):270. PubMed ID: 19295574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.